TREVI THERAPEUTICS INC's ticker is TRVI and the CUSIP is 89532M101. A total of 33 filers reported holding TREVI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,068 | +291.9% | 6,453 | +329.6% | 0.00% | – |
| Q2 2023 | $3,590 | -76.1% | 1,502 | -84.7% | 0.00% | – |
| Q3 2022 | $15,000 | +36.4% | 9,786 | +152.6% | 0.00% | – |
| Q2 2022 | $11,000 | -47.6% | 3,874 | -59.1% | 0.00% | – |
| Q1 2022 | $21,000 | +200.0% | 9,477 | +13.9% | 0.00% | – |
| Q4 2021 | $7,000 | 0.0% | 8,317 | +73.2% | 0.00% | – |
| Q3 2021 | $7,000 | -30.0% | 4,803 | +14.7% | 0.00% | – |
| Q2 2021 | $10,000 | +233.3% | 4,187 | +238.5% | 0.00% | – |
| Q1 2021 | $3,000 | -76.9% | 1,237 | -76.3% | 0.00% | – |
| Q4 2020 | $13,000 | +116.7% | 5,228 | +271.6% | 0.00% | – |
| Q3 2020 | $6,000 | -45.5% | 1,407 | -40.0% | 0.00% | -100.0% |
| Q3 2019 | $11,000 | +22.2% | 2,344 | +95.0% | 0.00% | 0.0% |
| Q2 2019 | $9,000 | – | 1,202 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 11,370,376 | $24,787,420 | 1.91% |
| Fairmount Funds Management LLC | 5,163,287 | $11,255,966 | 1.35% |
| Opaleye Management Inc. | 1,705,900 | $3,718,862 | 1.21% |
| Frazier Life Sciences Management, L.P. | 6,881,090 | $15,000,776 | 1.00% |
| VR Adviser, LLC | 3,422,397 | $7,460,825 | 0.78% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 927,415 | $2,021,765 | 0.61% |
| Rubric Capital Management LP | 5,684,420 | $12,392,036 | 0.46% |
| Tejara Capital Ltd | 180,227 | $392,895 | 0.22% |
| PFS Partners, LLC | 100,000 | $218,000 | 0.19% |
| WealthTrust Axiom LLC | 93,500 | $203,830 | 0.07% |